No, I am not on margin with ARQL. Yes, I am very tempted to buy some margined ( but would probably sell some others to buy and if do margin would not be huge). No, ARQL did not trade $4.50 (yet) from the latest downdraft. No, I did NOT buy on the way up after the Roche news. No, I unfortunately did not sell any either after the Roche news. Admit I NEVER expected to see low $4's after Roche news. 95% of my ARQL was bought bewteen $4.17 and the high $5's. With some that I did buy at $5.40 (that was only a few days ago!)..my cost is somewhere around $5-$5.15. If I get any more low to mid $4 stock...I will get average in high $4's again. YEs, ARQL is a gamble on Ph 1 results. Yes, imo it is a great gamble. ARQ-501 is VERY closey related to Taxol. And Taxol (cumulatively over time) is/was, one of the largest selling cancer drugs ever.(generic now). And since you bring up SCLN, you know full well miachaz my cost is well below where it is now. It is true I have $5-$8.50 stock in SCLN...but it is also a fact (posted) that on June 30 2002 (Russell kick out day) I bought many many thousands between $2.05 and $2.35.